Enliven Therapeutics, Inc. (ELVN): SCHEDULE 13G/A filed Feb 14, 2025

Form type

SCHEDULE 13G/A

Filing date

Feb 14, 2025

Accession number

0001172661-25-000912

Filer

Enliven Therapeutics, Inc. (CIK 1672619)